Limited data exists for: Understudied Populations: Adults over 75 years (increased sensitivity to appetite suppression) Adolescents (ongoing development considerations) Individuals with BMI under 27 (insufficient safety data) Pregnant or lactating individuals (no safety data) Individuals with significant psychiatric conditions Gender Considerations: Research suggests some metabolic peptides may show differential effects between males and females, though data for cagrilintide and retatrutide specifically remains limited
Our medical team tracks critical signs, manages potential side effects, and provides ongoing support to maximize long-term effectiveness
A research-focused microgram capsule format designed for precision, consistency, and controlled study workflows
** daily values not established OTHER INGREDIENTS: Deionised Water, L-Carnitine, Malic Acid, Green Tea Extract, Vitamin C, Sweeteners (Sucralose), Natural Flavoring, Preservatives (Potassium Sorbate, Sodium Benzoate), Colour (Caramel Extract)
Weight regain varies by individual, but many people begin regaining weight within the first few months after stopping semaglutide, with the early months representing the highest-risk period
PlexusDx serves all 50 states with no membership fees or hidden charges